Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


23.07.2018

1 Abdom Radiol (NY)
1 Adv Clin Exp Med
1 Ann Nucl Med
1 Ann R Coll Surg Engl
1 Ann Surg Oncol
10 Arch Esp Urol
1 Brachytherapy
1 Cancer Med
1 Case Rep Oncol
1 Clin Cancer Res
1 Clin Epigenetics
1 Clin Exp Immunol
1 Eur J Surg Oncol
1 Eur Urol
1 Eur Urol Focus
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Control Release
1 J Exp Clin Cancer Res
1 J Immunother
1 Methods Mol Biol
1 Oncol Lett
2 Oncol Rep
1 Pathol Oncol Res
1 Sci Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Abdom Radiol (NY)

  1. FAN TW, Malhi H, Varghese B, Cen S, et al
    Computed tomography-based texture analysis of bladder cancer: differentiating urothelial carcinoma from micropapillary carcinoma.
    Abdom Radiol (NY). 2018 Jul 18. pii: 10.1007/s00261-018-1694.
    PubMed     Text format     Abstract available


    Adv Clin Exp Med

  2. SWALARZ M, Swalarz G, Juszczak K, Maciukiewicz P, et al
    Correlation between malnutrition, body mass index and complications in patients with urinary bladder cancer who underwent radical cystectomy.
    Adv Clin Exp Med. 2018 Jul 18. doi: 10.17219/acem/89863.
    PubMed     Text format     Abstract available


    Ann Nucl Med

  3. HIGASHIYAMA A, Komori T, Juri H, Inada Y, et al
    Detectability of residual invasive bladder cancer in delayed (18)F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling.
    Ann Nucl Med. 2018 Jul 16. pii: 10.1007/s12149-018-1280.
    PubMed     Text format     Abstract available


    Ann R Coll Surg Engl

  4. HOSNY K, Luk A
    Urinary schistosomiasis presented as bladder malignancy with pulmonary metastases: a case report.
    Ann R Coll Surg Engl. 2018;100:e145-e146.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  5. HAUTMANN R, Bolenz C
    Declining Use of Orthotopic Reconstruction for Bladder Cancer.
    Ann Surg Oncol. 2018 Jul 18. pii: 10.1245/s10434-018-6570.
    PubMed     Text format    


    Arch Esp Urol

  6. RIOS GONZALEZ E, Martinez-Pineiro L
    [New endovesical chemotherapy drugs and application vehicles.]
    Arch Esp Urol. 2018;71:384-392.
    PubMed     Text format     Abstract available

  7. BARCLAY J, Creswell J, Leon J
    Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway.
    Arch Esp Urol. 2018;71:393-399.
    PubMed     Text format     Abstract available

  8. SOLSONA E
    [EMDA with MMC. Critical review.]
    Arch Esp Urol. 2018;71:409-416.
    PubMed     Text format     Abstract available

  9. SOUSA ESCANDON A, Leon Mata J, Sousa Gonzalez D, Alvarez Casal M, et al
    Neoadjuvant chemohyperthermia: Our experience after 10 years.
    Arch Esp Urol. 2018;71:438-446.
    PubMed     Text format     Abstract available

  10. DOMINGUEZ-ESCRIG JL
    [Immediate post TURBT MMC instillation.]
    Arch Esp Urol. 2018;71:376-383.
    PubMed     Text format     Abstract available

  11. CARBALLIDO JA, Rodriguez Monsalve M
    [Mechanism of action of intravesical BCG. Biological bases and clinical applicability.]
    Arch Esp Urol. 2018;71:358-375.
    PubMed     Text format     Abstract available

  12. SANCHEZ VAZQUEZ A, Pereira Arias JG, Gamarra Quintanilla M, Urdaneta Salegui F, et al
    [BCG therapy in NMIBC: How much and for how long?.]
    Arch Esp Urol. 2018;71:349-357.
    PubMed     Text format     Abstract available

  13. ASHTON A, Murthy Kusuma VR, Crew J, Mostafid AH, et al
    BCG therapy in NMIBC: How much and for how long?.
    Arch Esp Urol. 2018;71:342-348.
    PubMed     Text format     Abstract available

  14. UNDA-URZAIZ M
    [Future advances in the endovesical treatment of NMIBC.]
    Arch Esp Urol. 2018;71:328-331.
    PubMed     Text format    

  15. GUERRERO-RAMOS F, Castellano-Gauna D, Garcia-Rojo E, Duarte-Ojeda JM, et al
    [Mitomycin C HIVEC. Update and results in high risk patients.]
    Arch Esp Urol. 2018;71:417-425.
    PubMed     Text format     Abstract available


    Brachytherapy

  16. BUS SJEA, Leus NG, Oosterveld BJ, Van Gellekom MPR, et al
    An evaluation of our experience in position verification of catheters used for interstitial high-dose-rate brachytherapy of solitary bladder tumors.
    Brachytherapy. 2018;17:24-30.
    PubMed     Text format     Abstract available


    Cancer Med

  17. ZHANG XG, Zhang T, Li CY, Zhang MH, et al
    CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.
    Cancer Med. 2018 Jul 18. doi: 10.1002/cam4.1607.
    PubMed     Text format     Abstract available


    Case Rep Oncol

  18. KANO H, Miwa S, Koshida K, Kawai K, et al
    Successful Treatment of a Large Superficial Bladder Cancer with Neoadjuvant Arterial Infusion Chemotherapy: A Case Report.
    Case Rep Oncol. 2018;11:383-387.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  19. BIELLI P, Panzeri V, Lattanzio R, Mutascio S, et al
    The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer.
    Clin Cancer Res. 2018 Jul 16. pii: 1078-0432.CCR-17-3850.
    PubMed     Text format     Abstract available


    Clin Epigenetics

  20. PENG D, Ge G, Gong Y, Zhan Y, et al
    Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer.
    Clin Epigenetics. 2018;10:94.
    PubMed     Text format     Abstract available


    Clin Exp Immunol

  21. HARTANA CA, Ahlen Bergman E, Broome A, Berglund S, et al
    Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer.
    Clin Exp Immunol. 2018 Jul 15. doi: 10.1111/cei.13183.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  22. MOEEN AM, Safwat AS, Gadelmoula MM, Moeen SM, et al
    Does the site of the orthotopic neobladder outlet matter? A prospective randomized comparative study.
    Eur J Surg Oncol. 2018;44:847-852.
    PubMed     Text format     Abstract available


    Eur Urol

  23. ECKSTEIN M, Sikic D, Strissel PL, Erlmeier F, et al
    Evolution of PD-1 and PD-L1 Gene and Protein Expression in Primary Tumors and Corresponding Liver Metastases of Metastatic Bladder Cancer.
    Eur Urol. 2018 Jul 11. pii: S0302-2838(18)30456.
    PubMed     Text format    


    Eur Urol Focus

  24. STEINBERG RL, Thomas LJ, O'Donnell MA
    Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2018 Jul 13. pii: S2405-4569(18)30171.
    PubMed     Text format     Abstract available


    Int J Cancer

  25. WANG W, Yang C, Nie H, Qiu X, et al
    LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31757.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  26. TREE AC, Jones K, Hafeez S, Sharabiani MTA, et al
    Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2018;101:1168-1171.
    PubMed     Text format     Abstract available


    Int J Urol

  27. ZHANG D, Zhou C, Li Y, Gao L, et al
    Amyloid precursor protein is overexpressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
    Int J Urol. 2018 Jul 18. doi: 10.1111/iju.13726.
    PubMed     Text format     Abstract available


    J Control Release

  28. GUO P, Shang W, Peng L, Wang L, et al
    A gel system for single instillation of non-muscle-invasive bladder Cancer: A "divide-and-rule" strategy.
    J Control Release. 2018;285:46-55.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  29. CHEN M, Wu R, Li G, Liu C, et al
    Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.
    J Exp Clin Cancer Res. 2018;37:154.
    PubMed     Text format     Abstract available


    J Immunother

  30. GARJE R, Chau JJ, Chung J, Wanat K, et al
    Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer.
    J Immunother. 2018;41:42-44.
    PubMed     Text format     Abstract available


    Methods Mol Biol

  31. HUSSMANN D, Hansen LL
    Methylation-Sensitive High Resolution Melting (MS-HRM).
    Methods Mol Biol. 2018;1708:551-571.
    PubMed     Text format     Abstract available


    Oncol Lett

  32. CHU J, Li N, Li F
    A risk score staging system based on the expression of seven genes predicts the outcome of bladder cancer.
    Oncol Lett. 2018;16:2091-2096.
    PubMed     Text format     Abstract available


    Oncol Rep

  33. ZHANG T, Yang F, Li W, Liu B, et al
    Suppression of the SDF1/CXCR4/betacatenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
    Oncol Rep. 2018 Jul 4. doi: 10.3892/or.2018.6546.
    PubMed     Text format     Abstract available

  34. ZHANG H, Qi D, Li J, Peng T, et al
    A novel regulatory circuit of miR152 and DNMT1 in human bladder cancer.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6553.
    PubMed     Text format     Abstract available


    Pathol Oncol Res

  35. KRAFFT U, Reis H, Ingenwerth M, Kovalszky I, et al
    Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer.
    Pathol Oncol Res. 2018 Jul 17. pii: 10.1007/s12253-018-0447.
    PubMed     Text format     Abstract available


    Sci Rep

  36. SAHEB SHARIF-ASKARI N, Bendardaf R, Saheb Sharif-Askari F, El Tabbal AM, et al
    Incidence of bladder cancer in Benghazi, Libya over the past three decades.
    Sci Rep. 2018;8:10822.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: